RP Warrell… - The New England journal of medicine, 1993 - nejm.highwire.org Discoveries in cancer research are rarely so exceptional that they both cause immediate changes
in the treatment of patients and dramatically advance our understanding of the mechanisms underlying
the disease. However, observations of the striking efficacy of all-trans-retinoic acid ... Cited by 496 - Related articles - All 7 versions
- ►nevada.edu [PDF] JS Menell, GM Cesarman, AT Jacovina, MA … - New England Journal …, 1999 - content.nejm.org Results The expression of annexin II, as detected by a fluorescein-tagged antibody, was greater
on leukemic cells from patients with APL than on other types of leukemic cells (mean fluorescence
intensity, 6.9 and 2.9, respectively; P<0.01). The t(15;17)-positive APL cells stimulated the ... Cited by 226 - Related articles - BL Direct - All 9 versions
- ►bearscampnewfs.com [PDF] RL Bick, B Arun, EP Frenkel - Pathophysiology of Haemostasis and …, 2000 - content.karger.com Disseminated intravascular coagulation (DIC) is a complex disorder, with pathophysiology being
variable and highly dependent upon the triggering event(s), host response(s) and comorbid
conditions. As a result of these complicated interactions, the clinical expression and ... Cited by 210 - Related articles - BL Direct - All 10 versions
FR Rickles, M Levine, RL Edwards - Cancer and Metastasis Reviews, 1992 - Springer Nearly all patients with cancer manifest laboratory evidence of hypercoagulability and some
develop clinical thromboembolic disease (TED). Routine laboratory studies of blood coagulation
have been performed in several large, prospective trials of the use of anticoagulant drugs ... Cited by 209 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org [PDF] F Rodeghiero, G Avvisati, G Castaman, T … - …, 1990 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ... Cited by 127 - Related articles - All 3 versions
- ►ascopubs.org [PDF] RM Stone, RJ Mayer - Journal of Clinical Oncology, 1990 - jco.ascopubs.org A CUTE promyelocytic leukemia (APL) is a distinct subset of acute myeloid leukemia (AML) associated
with unique features and requiring specific management. Initially identi- fied in 1957 by
Hillestad' who described three patients with rapidly fatal acute leukemia having an ... Cited by 101 - Related articles - All 7 versions
KE Goad, HR Gralnick - Hematology/oncology clinics of North America, 1996 - Elsevier Approximately 90% of cancer patients with metastatic disease, 82 and 279 and half of all cancer
patients, have abnormal coagulation parameters. 82 , 125 , 180 , 204 , 233 , 279 , 295 and 306
Thrombocytosis and increased plasma fibrinogen levels were the most common ... Cited by 82 - Related articles - BL Direct - All 3 versions
S Nand, H Messmore - Am J Hematol, 1990 - interscience.wiley.com Hemostatic abnormalities are present in a majority of patients with metastatic cancer. These abnormalities
can be categorized as 1) increased platelet aggregation and activation, 2) abnormal activation
of coagulation cascade, 3) release of plasminogen activator, and 4) decreased hepatic ... Cited by 64 - Related articles - All 2 versions
H Takahashi, W Tatewaki, K Wada, M Hanano, A … - Am J …, 1990 - interscience.wiley.com In order to assess the thrombin and plasmin generation in vivo in disseminated intravascular
coagulation (DIC), plasma levels of thrombin-antithrombin III (ATIII) complex (TAT) and
plasmin-alpha 2-antiplasmin (a2AP) complex (PAP) were measured together with ... Cited by 53 - Related articles - All 3 versions
DL Cooper, AB Sander, LD Wilson, TP … - CA A Cancer Journal for … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 36 - Related articles - All 4 versions
